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 Australians’ Medicare details online 
and been sold – July, 2017 
 Encrypted private medical records 
released – August, 2016 
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Legal framework on health data privacy 
 In Australia: both federal and state & territory legislation pertinent 
to health data and health data breaches 
 Provisions in these laws which make unauthorised access to 
(health) data illegal  
 Similar laws exist in other countries eg HIPAA in the US, the new 
General Data Protection Regulation in the EU 
 Here, we use HIPAA as an example of legislative requirements 
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HIPAA Rule: “Covered entities must obtain patient authorization before they use 
or disclose PHI for marketing purposes.  Under the Privacy Rule, ‘marketing’ means 
communicating about a product or service in a way that encourages a recipient to 
purchase or use the product or service.  Whether a communication is ‘marketing’ 
often depends on whether the covered entity is paid in exchange for encouraging a 
product or service.  If  a covered entity is receiving payment to market a product or 
service, that must be included in the authorization”. 
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Case Scenario: Patient P has been admitted for treatments for a heart attack and has been 
released from the hospital. Doctor Dx has been granted access to the full details of  Patient P's 
medical history in the critical time period of  Patient P where earlier, Doctor Dx was not allowed 
to access all the details of  Patient P. P, being a celebrity, media is interested in knowing much 
information about the incident. A media representative has motivated Dx to provide P’s full 
health information for a considerable cost. The media representative makes a lucrative deal with 
Dr. Dx to have the full health information of  Patient P. Dx accesses the patient's EHR, including 
mental health information, pretending it is an emergency situation in order to collect necessary 
information for the media representative. 
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 Wha  vents n ed to be logged? 
 What should be included whe  logging such ev nts? 
Conformance Checking 
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Conformance Reports 
Summary 
 We are proposing log requirements and audit processes that 
facilitate evidence in HISs to improve patients’ information privacy 
in accordance with legal requirements.  
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